A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

June 30, 2019

Conditions
Esophageal Cancer
Interventions
BIOLOGICAL

OBP-301

OBP-301 administration on the Day 1, Day 18 and Day 32

RADIATION

Radiation

Standard radiation therapy for esophageal cancer patient. total 60 Gy for 6 weeks

Trial Locations (2)

Unknown

RECRUITING

Research site, Kashima-shi

RECRUITING

Research site, Kita

Sponsors
All Listed Sponsors
lead

Oncolys BioPharma Inc

INDUSTRY

NCT03213054 - A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter